BetterLife Pharma Appoints Henry Chow, CPA, CA, to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotechnology company developing BETR-001 for chronic cluster headache and chronic migraine, today announced that Ralph Anthony ("Tony") Pullen has resigned from the Company's Board of Directors, effective November 4, 2026, and will remain with the Company as an advisor. The Board has appointed Henry Chow, CPA, CA, as a...
Free plan · Plus CA$29 or Pro CA$99/month


